# NK Cell Infusion for Patients With Acute Myeloid Leukemia

> **NCT04221971** · PHASE1 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** chemotherapy combined with NK cells infusion

## Key facts

- **NCT ID:** NCT04221971
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10
- **Primary completion:** 2021-04
- **Final completion:** 2022-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221971, "NK Cell Infusion for Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04221971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*